132 related articles for article (PubMed ID: 1727916)
1. Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.
Berg SL; Balis FM; Zimm S; Murphy RF; Holcenberg J; Sato J; Reaman G; Steinherz P; Gillespie A; Doherty K
J Clin Oncol; 1992 Jan; 10(1):143-8. PubMed ID: 1727916
[TBL] [Abstract][Full Text] [Related]
2. Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
Meyers PA; Tan CT; Steinherz PG; Redner A
Cancer; 1989 Dec; 64(12):2416-9. PubMed ID: 2479459
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of diaziquone (AZQ) plus GM-CSF.
Hartmann LC; Ames MM; Reid JM; Richardson RL
Invest New Drugs; 1995; 13(2):175-6. PubMed ID: 8617583
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
[TBL] [Abstract][Full Text] [Related]
5. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study.
Stiff PJ; McKenzie RS; Potempa LD; Albain K; Koch D; Braud E; Bansal VK; Weidner MK; Lanzotti VJ; Chun HG
J Clin Oncol; 1991 Aug; 9(8):1487-94. PubMed ID: 2072148
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
Tan CT; Hancock CH; Mondora A; Hoffman NW
Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic approaches to the treatment of meningeal malignancy.
Blaney SM; Balis FM; Poplack DG
Oncology (Williston Park); 1991 May; 5(5):107-16; discussion 123, 127. PubMed ID: 1831994
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
Bomgaars L; Geyer JR; Franklin J; Dahl G; Park J; Winick NJ; Klenke R; Berg SL; Blaney SM
J Clin Oncol; 2004 Oct; 22(19):3916-21. PubMed ID: 15459213
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study.
Adamson PC; Balis FM; Arndt CA; Holcenberg JS; Narang PK; Murphy RF; Gillespie AJ; Poplack DG
Cancer Res; 1991 Nov; 51(22):6079-83. PubMed ID: 1933871
[TBL] [Abstract][Full Text] [Related]
12. Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study.
Falletta JM; Cushing B; Lauer S; Bell B; Mahoney DH; Castleberry R; Krance RA
Invest New Drugs; 1990 May; 8(2):167-70. PubMed ID: 2384303
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial of diaziquone (AZQ) in mixed mesodermal sarcomas of the uterus. A Gynecologic Oncology Group study.
Slayton RE; Blessing JA; Clarke-Pearson D
Invest New Drugs; 1991 Feb; 9(1):93-4. PubMed ID: 2026490
[TBL] [Abstract][Full Text] [Related]
14. Protracted intermittent schedule of topotecan in children with refractory acute leukemia: a pediatric oncology group study.
Furman WL; Stewart CF; Kirstein M; Kepner JL; Bernstein ML; Kung F; Vietti TJ; Steuber CP; Becton DL; Baruchel S; Pratt C
J Clin Oncol; 2002 Mar; 20(6):1617-24. PubMed ID: 11896112
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of diaziquone.
Frytak S; Eagan RT; Ames MM; Creagan ET; Nichols WC
Cancer Treat Rep; 1984; 68(7-8):975-8. PubMed ID: 6744349
[TBL] [Abstract][Full Text] [Related]
16. Phase I clinical evaluation of diaziquone in childhood cancer.
Ettinger LJ; Siegel SE; Belasco JB; Evans AE; Ruccione KS; Jamin DC; Rohrbaugh TM; Higgins GR
Cancer Treat Rep; 1985 Mar; 69(3):323-7. PubMed ID: 3856480
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.
Fleischhack G; Jaehde U; Bode U
Clin Pharmacokinet; 2005; 44(1):1-31. PubMed ID: 15634030
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.
Høst H; Joss R; Pinedo H; Bruntsch U; Cavalli F; Renard G; van Glabbeke M; Rozencweig M
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):295-8. PubMed ID: 6681775
[TBL] [Abstract][Full Text] [Related]
19. Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.
Blaney SM; Heideman R; Berg S; Adamson P; Gillespie A; Geyer JR; Packer R; Matthay K; Jaeckle K; Cole D; Kuttesch N; Poplack DG; Balis FM
J Clin Oncol; 2003 Jan; 21(1):143-7. PubMed ID: 12506183
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group.
Ettinger LJ; Ru N; Krailo M; Ruccione KS; Krivit W; Hammond GD
J Neurooncol; 1990 Aug; 9(1):69-76. PubMed ID: 2213117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
